These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart. Farkas A, Qureshi A, Curtis MJ. Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833 [Abstract] [Full Text] [Related]
24. Changes in canine ventricular fibrillation threshold induced by verapamil, flecainide and bretylium. Quesada A, Sanchis J, Chorro FJ, Burguera MA, Alberola A, Such L, Lopez-Merino V. Eur Heart J; 1993 May; 14(5):712-6. PubMed ID: 8508866 [Abstract] [Full Text] [Related]
25. The vulnerable period for low and high energy T-wave shocks: role of dispersion of repolarisation and effect of d-sotalol. Kirchhof PF, Fabritz CL, Zabel M, Franz MR. Cardiovasc Res; 1996 Jun; 31(6):953-62. PubMed ID: 8759252 [Abstract] [Full Text] [Related]
34. Comparative study of the effect of slow channel inhibiting agents on ischemia-induced conduction delay as relevant to the genesis of ventricular fibrillation. Peter T, Fujimoto T, Hamamoto H, Mandel WJ. Am Heart J; 1983 Nov 01; 106(5 Pt 1):1023-8. PubMed ID: 6637762 [Abstract] [Full Text] [Related]
35. Existence of both fast and slow channel activity during the early stages of ventricular fibrillation. Zhou X, Guse P, Wolf PD, Rollins DL, Smith WM, Ideker RE. Circ Res; 1992 Apr 01; 70(4):773-86. PubMed ID: 1312912 [Abstract] [Full Text] [Related]